Patient revenues have significantly dropped below patient enrollment increases in the last two years. This drop indicates patients are being forced into the black market for their cannabis needs. In addition, the Medical Cannabis Program is only allowing commercial providers to produce 11% of total supply needed due to overly restrictive plant count limitations.
Patient revenues have significantly dropped below patient enrollment increases in the last two years. This drop indicates patients are being forced into the black market for their cannabis needs. In addition, the Medical Cannabis Program is only allowing commercial providers to produce 11% of total supply needed due to overly restrictive plant count limitations.